Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Histologically-confirmed Advanced Cancer”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Early research (Phase 1)Study completedNCT00736372
What this trial is testing

A Trial of PX-12 in Patients With a Histologically or Cytologically Confirmed Diagnosis of Advanced or Metastatic Cancer

Who this might be right for
Metastatic CancerAdvanced Cancer
Cascadian Therapeutics Inc. 14
Early research (Phase 1)Study completedNCT01165905
What this trial is testing

Safety of 24-hour Infusion of ON 01910.Na in Combination With Gemcitabine in Advanced Solid Tumors

Who this might be right for
Solid Tumor
Traws Pharma, Inc. 10
Testing effectiveness (Phase 2)Looking for participantsNCT07104149
What this trial is testing

Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer

Who this might be right for
Female, Age ≥ 18 Years OldNo Previous Systemic Treatment for the Current Disease, Including Surgery, Antitumor Radiochemotherapy/ImmunotherapyECOG Score of 0-1+6 more
The First Affiliated Hospital of Zhengzhou University 29
Early research (Phase 1)Ended earlyNCT01278849
What this trial is testing

An Open-label, Dose Escalation Study to Assess the Pharmacokinetics of of ASA404 in Adult Cancer Patients With Impaired Hepatic Function

Who this might be right for
Histologically-proven and Radiologically-confirmed Solid Tumors
Novartis Pharmaceuticals 5
Early research (Phase 1)Study completedNCT01294358
What this trial is testing

Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial

Who this might be right for
Histologically or Cytologically Confirmed Pancreatic CaUnresectable or Borderline Resectable Pancreatic Ca
National Cancer Institute (NCI) 7
Not applicableLooking for participantsNCT07173868
What this trial is testing

FDG PET-CT in Advanced Breast Cancer

Who this might be right for
Histologically Confirmed Metastatic or Locally Advanced Breast Cancer With no Radical Topical Treatment AvailableIf There is Liver Metastasis, Which the Researcher Believes Will be Difficult to Evaluate the Response Accurately With Bone Metastasis or CT
Samsung Medical Center 100
Early research (Phase 1)Study completedNCT00338026
What this trial is testing

A Phase I Study of ECO-4601 in Patients With Advanced Cancer

Who this might be right for
TumorsGliomaColorectal Cancer+5 more
Thallion Pharmaceuticals 26
Early research (Phase 1)Study completedNCT01320592
What this trial is testing

PD0332991/Paclitaxel in Advanced Breast Cancer

Who this might be right for
Breast Cancer
Abramson Cancer Center at Penn Medicine 28
Testing effectiveness (Phase 2)Ended earlyNCT04327986
What this trial is testing

Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Advanced Pancreas Cancer

Who this might be right for
Histologically or Cytologically Confirmed Pancreatic CancerUnresectable or Borderline Resectable Pancreatic CancerPancreatic Neoplasms+2 more
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Study completedNCT00171587
What this trial is testing

Study of the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced Cancer

Who this might be right for
TumorsNeoplasm Metastasis
Novartis 22
Testing effectiveness (Phase 2)Study completedNCT00753714
What this trial is testing

Zactima in Non Small Cell Lung Cancer (NSCLC) ELderly Patients In Combination With or Versus Gemcitabine

Who this might be right for
Non Small Cell Lung Cancer
Genzyme, a Sanofi Company 124
Early research (Phase 1)Study completedNCT01324479
What this trial is testing

Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors

Who this might be right for
Solid Tumors
Novartis Pharmaceuticals 131
Testing effectiveness (Phase 2)Study completedNCT05337137
What this trial is testing

Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer

Who this might be right for
Carcinoma, Hepatocellular
Bristol-Myers Squibb 83
Early research (Phase 1)Study completedNCT01795586
What this trial is testing

A Phase I Dose Escalation Study of Eribulin Plus Weekly Carboplatin for Metastatic Breast Patients

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 19
Large-scale testing (Phase 3)Ended earlyNCT00412776
What this trial is testing

Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer

Who this might be right for
Carcinoma, Squamous Cell of Head and NeckCarcinoma, Squamous CellNeoplasms, Squamous Cell+3 more
Sesen Bio, Inc. 165
Early research (Phase 1)Study completedNCT02036281
What this trial is testing

Substance P-Saporin in Terminal Cancer Patients With Intractable Pain

Who this might be right for
Terminally IllHistologically-confirmed Advanced CancerPain, Intractable
University of Texas Southwestern Medical Center 23
Testing effectiveness (Phase 2)Study completedNCT03112590
What this trial is testing

Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer

Who this might be right for
Breast CancerBreast Cancer, MaleBreast Cancer Female+1 more
H. Lee Moffitt Cancer Center and Research Institute 51
Large-scale testing (Phase 3)Study completedNCT02599402
What this trial is testing

Nivolumab Combined With Ipilimumab Followed by Nivolumab Monotherapy as First-Line Treatment for Patients With Advanced Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 533
Early research (Phase 1)Study completedNCT01189929
What this trial is testing

Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
OncoMed Pharmaceuticals, Inc. 57
Early research (Phase 1)Study completedNCT01202032
What this trial is testing

Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors

Who this might be right for
Metastatic Renal Cell CarcinomaAdvanced Refractory Solid Tumors Histologically or Cytologically Confirmed
Centre Leon Berard 36
Load More Results